Abstract
HLA-A, -B, -C, -DR, -DQ antigens were studied in 43 multiple sclerosis (MS) patients with clinically definite remittent sclerosis from Asturias (North Spain). The prevalence of HLA-B7, B7 and B27 were significantly increased in MS. HLA-B35 was under-represented in these patients. DR2 was increased but not significantly. No association with DQw1 was discovered. The existence of several susceptibility factors in the more common B7/DR2/DQw1 haplotype is discussed.
Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arnaiz-Villena A., Rodriguez de Córdoba S., Vela F., Pascual J. C., Cerveró J., Bootello A. HLA antigens in a sample of the Spanish population: common features among Spaniards, Basques, and Sardinians. Hum Genet. 1981;58(3):344–348. doi: 10.1007/BF00294935. [DOI] [PubMed] [Google Scholar]
- Batchelor J. R., Compston A., McDonald W. I. The significance of the association between HLA and multiple sclerosis. Br Med Bull. 1978 Sep;34(3):279–284. doi: 10.1093/oxfordjournals.bmb.a071512. [DOI] [PubMed] [Google Scholar]
- Francis D. A., Batchelor J. R., McDonald W. I., Hing S. N., Dodi I. A., Fielder A. H., Hern J. E., Downie A. W. Multiple sclerosis in north-east Scotland. An association with HLA-DQw1. Brain. 1987 Feb;110(Pt 1):181–196. doi: 10.1093/brain/110.1.181. [DOI] [PubMed] [Google Scholar]
- Georgaras A., Constantopoulos C., Lygidacis C., Zervas J. HLA antigens and multiple sclerosis in Greeks. J Neurol Neurosurg Psychiatry. 1984 Jul;47(7):751–752. doi: 10.1136/jnnp.47.7.751-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hawkins B. R., Yu Y. L., Woo E., Huang C. Y. No apparent association between HLA and multiple sclerosis in southern Chinese. J Neurol Neurosurg Psychiatry. 1988 Mar;51(3):443–445. doi: 10.1136/jnnp.51.3.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kurtzke J. F. Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region. Acta Neurol Scand. 1980 Aug;62(2):65–80. doi: 10.1111/j.1600-0404.1980.tb03006.x. [DOI] [PubMed] [Google Scholar]
- Marcadet A., Massart C., Semana G., Fauchet R., Sabouraud O., Merienne M., Dausset J., Cohen D. Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis. Immunogenetics. 1985;22(1):93–96. doi: 10.1007/BF00430598. [DOI] [PubMed] [Google Scholar]
- Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
- Svejgaard A., Jersild C., Nielsen L. S., Bodmer W. F. HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens. 1974;4(2):95–105. doi: 10.1111/j.1399-0039.1974.tb00230.x. [DOI] [PubMed] [Google Scholar]
